2021 Satellite Symposia Schedule

Satellite Symposia will be offered in the following times (subject to review and approval of content).

Monday, February 08, 2021, 12:00 – 1:00 PM
Interpreting the evidence for Fabry disease: from clinical trials to real-world experience
Supported by Amicus Therapeutics, Inc.

Monday, February 08, 2021, 12:00 – 1:00 PM
Hallmarks of Acid Sphingomyelinase Deficiency (ASMD) and Assessment of Disease Progression
Supported by Sanofi Genzyme.

Monday, February 08, 2021, 4:00 – 5:30 PM
Rare Disease Registries: Pioneering Real World Evidence and a Continued Commitment to the Rare Disease Community
Supported by Sanofi Genzyme.

Monday, February 08, 2021, 4:00 – 5:30 PM
The role of Heat Shock Proteins in Lysosomal Storage Diseases
Supported by Orphazyme.

Tuesday, February 09, 2021, 12:00 – 1:00 PM
Management of Fabry Disease
Supported by Sanofi Genzyme.

Tuesday, February 09, 2021, 12:00 – 1:00 PM
Long-term follow-up on MPS IVA – What we have learned
Supported by BioMarin Pharmaceutical Inc.

Tuesday, February 09, 2021, 4:00 – 5:30 PM
Uncovering multiple mechanisms of Fabry disease – implications for management
Supported by Amicus Therapeutics, Inc.

Tuesday, February 09, 2021, 4:00 – 5:30 PM
Pompe Disease Around the World
Supported by Sanofi Genzyme.

Wednesday, February 10, 2021, 12:00 – 1:00 PM
Pompe disease from the inside out: GAA processing, pathogenic cascade and the LOPD patient perspective
Supported by Amicus Therapeutics, Inc.

Wednesday, February 10, 2021, 12:00 – 1:00 PM
Harnessing the Power of Ex-vivo Lentiviral Gene Therapy: A personalized approach
Supported by AVROBIO, Inc.

Wednesday, February 10, 2021, 12:00 – 1:00 PM
TBA

Wednesday, February 10, 2021, 4:00 – 5:30 PM
Therapeutic Advances in Metachromatic Leukodystrophy
Supported by Orchard.

Thursday, February 11, 2021, 12:00 – 1:00 PM
How has Fabry disease knowledge evolved over the past 20 years? Analysis of recent evidence.
Supported by Sanofi Genzyme.

Thursday, February 11, 2021, 12:00 – 1:00 PM
Critical Impact of Inflammation in Lysosomal Diseases: Unlocking Future Treatments and Improving Outcomes
CME Satellite Symposium.
Accredited provider: Postgraduate Institute for Medicine.
Supported by an independent educational grant from Takeda.

Thursday, February 11, 2021, 4:00 – 5:30 PM
Fabry Disease in the Era of COVID-19: Implications for Clinical Practice
Supported by Chiesi USA, Inc.

Thursday, February 11, 2021, 4:00 – 5:30 PM
Unmet need in Gaucher Disease: future possibilities with ex-vivo lentiviral gene therapy
Supported by AVROBIO, Inc.

Friday, February 12, 2021, 12:00 – 1:00 PM
Neurobehavioral and cognitive function in MPS II: a case-led look at effective clinical assessment
Supported by Takeda.

Friday, February 12, 2021, 12:00 – 1:00 PM
Niemann-Pick Type C: Understanding, evaluating, and treating the disease
Supported by Orphazyme.

Titles and content for Satellite Symposia will be posted as information becomes available.

These Satellite Symposia are not part of the official WORLDSymposium™ program, and WORLDSymposium does not approve or endorse any commercial products or services discussed during the Satellite Symposia or offered for sale by any corporate supporter of the Satellite Symposia. These symposia may or may not offer CME credits; these sessions are not approved for CME through WORLDSymposium.

Eligibility: Registration for WORLDSymposium 2021 are required to attend satellite symposia.